2018-2023 Global Osteoarthritis Pain Drugs Consumption Market Report

Publisher Name :
Date: 06-Jun-2018
No. of pages: 164

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Osteoarthritis Pain Drugs market for 2018-2023.

The main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis, osteoarthritis in the use of two kinds of painkillers:

Painkillers only: Only a simple analgesic effect, but no anti-inflammatory function, such as acetaminophen, tramadol. Acetaminophen side effects, but the analgesic effect is relatively weak, mainly for mild to moderate pain; tramadol analgesic effect is strong, but also side effects are larger, mainly gastrointestinal side effects such as nausea, vomiting and so on.

NSAIDs: With both anti-inflammatory and analgesic effect, suitable for inflammatory pain, for the acute phase of osteoarthritis, joint swelling of the patients to relieve symptoms better. These drugs may lead to nausea, vomiting and other gastrointestinal discomfort, but also increase the risk of gastrointestinal bleeding, so patients with gastro duodenal ulcer in the application of these drugs should consult a digestive physician, plus gastric mucosal protection Drugs or antacid drugs.

Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are injected into a joint.

Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement.

The USA osteoarthritis pain drugs market is very concerted market; the revenue of eleven manufacturers accounts about 88% of the total revenue in 2016. The high-end products mainly come from USA and Europe.

The leading manufactures mainly are Johnson & Johnson, Pfizer and GlaxoSmithKline. Johnson & Johnson is the largest manufacturer; its revenue of USA market exceeds 27% in 2016. The next is Pfizer and GlaxoSmithKline.

Over the next five years, LPI(LP Information) projects that Osteoarthritis Pain Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Osteoarthritis Pain Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- Oral

- Injection

- External

Segmentation by application:

- Medical Care

- Personal Care

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- Johnson & Johnson

- Pfizer

- GlaxoSmithKline

- Mylan

- Lilly

- Sanofi

- Abbott Laboratories

- Bayer

- Almatica Pharma

- TEVA

- Iroko Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Osteoarthritis Pain Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Osteoarthritis Pain Drugs market by identifying its various subsegments.

- Focuses on the key global Osteoarthritis Pain Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Osteoarthritis Pain Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Osteoarthritis Pain Drugs submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

2018-2023 Global Osteoarthritis Pain Drugs Consumption Market Report

Table of Contents

2018-2023 Global Osteoarthritis Pain Drugs Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Osteoarthritis Pain Drugs Consumption 2013-2023
2.1.2 Osteoarthritis Pain Drugs Consumption CAGR by Region
2.2 Osteoarthritis Pain Drugs Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 External
2.3 Osteoarthritis Pain Drugs Consumption by Type
2.3.1 Global Osteoarthritis Pain Drugs Consumption Market Share by Type (2013-2018)
2.3.2 Global Osteoarthritis Pain Drugs Revenue and Market Share by Type (2013-2018)
2.3.3 Global Osteoarthritis Pain Drugs Sale Price by Type (2013-2018)
2.4 Osteoarthritis Pain Drugs Segment by Application
2.4.1 Medical Care
2.4.2 Personal Care
2.5 Osteoarthritis Pain Drugs Consumption by Application
2.5.1 Global Osteoarthritis Pain Drugs Consumption Market Share by Application (2013-2018)
2.5.2 Global Osteoarthritis Pain Drugs Value and Market Share by Application (2013-2018)
2.5.3 Global Osteoarthritis Pain Drugs Sale Price by Application (2013-2018)

3 Global Osteoarthritis Pain Drugs by Players
3.1 Global Osteoarthritis Pain Drugs Sales Market Share by Players
3.1.1 Global Osteoarthritis Pain Drugs Sales by Players (2016-2018)
3.1.2 Global Osteoarthritis Pain Drugs Sales Market Share by Players (2016-2018)
3.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Players
3.2.1 Global Osteoarthritis Pain Drugs Revenue by Players (2016-2018)
3.2.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Osteoarthritis Pain Drugs Sale Price by Players
3.4 Global Osteoarthritis Pain Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Osteoarthritis Pain Drugs Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Osteoarthritis Pain Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Osteoarthritis Pain Drugs by Regions
4.1 Osteoarthritis Pain Drugs by Regions
4.1.1 Global Osteoarthritis Pain Drugs Consumption by Regions
4.1.2 Global Osteoarthritis Pain Drugs Value by Regions
4.2 Americas Osteoarthritis Pain Drugs Consumption Growth
4.3 APAC Osteoarthritis Pain Drugs Consumption Growth
4.4 Europe Osteoarthritis Pain Drugs Consumption Growth
4.5 Middle East & Africa Osteoarthritis Pain Drugs Consumption Growth

5 Americas
5.1 Americas Osteoarthritis Pain Drugs Consumption by Countries
5.1.1 Americas Osteoarthritis Pain Drugs Consumption by Countries (2013-2018)
5.1.2 Americas Osteoarthritis Pain Drugs Value by Countries (2013-2018)
5.2 Americas Osteoarthritis Pain Drugs Consumption by Type
5.3 Americas Osteoarthritis Pain Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Osteoarthritis Pain Drugs Consumption by Countries
6.1.1 APAC Osteoarthritis Pain Drugs Consumption by Countries (2013-2018)
6.1.2 APAC Osteoarthritis Pain Drugs Value by Countries (2013-2018)
6.2 APAC Osteoarthritis Pain Drugs Consumption by Type
6.3 APAC Osteoarthritis Pain Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Osteoarthritis Pain Drugs by Countries
7.1.1 Europe Osteoarthritis Pain Drugs Consumption by Countries (2013-2018)
7.1.2 Europe Osteoarthritis Pain Drugs Value by Countries (2013-2018)
7.2 Europe Osteoarthritis Pain Drugs Consumption by Type
7.3 Europe Osteoarthritis Pain Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Osteoarthritis Pain Drugs by Countries
8.1.1 Middle East & Africa Osteoarthritis Pain Drugs Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Osteoarthritis Pain Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Osteoarthritis Pain Drugs Consumption by Type
8.3 Middle East & Africa Osteoarthritis Pain Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Osteoarthritis Pain Drugs Distributors
10.3 Osteoarthritis Pain Drugs Customer

11 Global Osteoarthritis Pain Drugs Market Forecast
11.1 Global Osteoarthritis Pain Drugs Consumption Forecast (2018-2023)
11.2 Global Osteoarthritis Pain Drugs Forecast by Regions
11.2.1 Global Osteoarthritis Pain Drugs Forecast by Regions (2018-2023)
11.2.2 Global Osteoarthritis Pain Drugs Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Osteoarthritis Pain Drugs Forecast by Type
11.8 Global Osteoarthritis Pain Drugs Forecast by Application

12 Key Players Analysis
12.1 Johnson & Johnson
12.1.1 Company Details
12.1.2 Osteoarthritis Pain Drugs Product Offered
12.1.3 Johnson & Johnson Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Johnson & Johnson News
12.2 Pfizer
12.2.1 Company Details
12.2.2 Osteoarthritis Pain Drugs Product Offered
12.2.3 Pfizer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Pfizer News
12.3 GlaxoSmithKline
12.3.1 Company Details
12.3.2 Osteoarthritis Pain Drugs Product Offered
12.3.3 GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 GlaxoSmithKline News
12.4 Mylan
12.4.1 Company Details
12.4.2 Osteoarthritis Pain Drugs Product Offered
12.4.3 Mylan Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Mylan News
12.5 Lilly
12.5.1 Company Details
12.5.2 Osteoarthritis Pain Drugs Product Offered
12.5.3 Lilly Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Lilly News
12.6 Sanofi
12.6.1 Company Details
12.6.2 Osteoarthritis Pain Drugs Product Offered
12.6.3 Sanofi Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Sanofi News
12.7 Abbott Laboratories
12.7.1 Company Details
12.7.2 Osteoarthritis Pain Drugs Product Offered
12.7.3 Abbott Laboratories Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Abbott Laboratories News
12.8 Bayer
12.8.1 Company Details
12.8.2 Osteoarthritis Pain Drugs Product Offered
12.8.3 Bayer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Bayer News
12.9 Almatica Pharma
12.9.1 Company Details
12.9.2 Osteoarthritis Pain Drugs Product Offered
12.9.3 Almatica Pharma Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Almatica Pharma News
12.10 TEVA
12.10.1 Company Details
12.10.2 Osteoarthritis Pain Drugs Product Offered
12.10.3 TEVA Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 TEVA News
12.11 Iroko Pharmaceuticals

13 Research Findings and Conclusion


List of Tables and Figures

Figure Picture of Osteoarthritis Pain Drugs
Table Product Specifications of Osteoarthritis Pain Drugs
Figure Osteoarthritis Pain Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Osteoarthritis Pain Drugs Consumption Growth Rate 2013-2023 (M Dose)
Figure Global Osteoarthritis Pain Drugs Value Growth Rate 2013-2023 ($ Millions)
Table Osteoarthritis Pain Drugs Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Oral
Table Major Players of Oral
Figure Product Picture of Injection
Table Major Players of Injection
Figure Product Picture of External
Table Major Players of External
Table Global Consumption Sales by Type (2013-2018)
Table Global Osteoarthritis Pain Drugs Consumption Market Share by Type (2013-2018)
Figure Global Osteoarthritis Pain Drugs Consumption Market Share by Type (2013-2018)
Table Global Osteoarthritis Pain Drugs Revenue by Type (2013-2018) ($ million)
Table Global Osteoarthritis Pain Drugs Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Osteoarthritis Pain Drugs Value Market Share by Type (2013-2018)
Table Global Osteoarthritis Pain Drugs Sale Price by Type (2013-2018)
Figure Osteoarthritis Pain Drugs Consumed in Medical Care
Figure Global Osteoarthritis Pain Drugs Market: Medical Care (2013-2018) (M Dose)
Figure Global Osteoarthritis Pain Drugs Market: Medical Care (2013-2018) ($ Millions)
Figure Global Medical Care YoY Growth ($ Millions)
Figure Osteoarthritis Pain Drugs Consumed in Personal Care
Figure Global Osteoarthritis Pain Drugs Market: Personal Care (2013-2018) (M Dose)
Figure Global Osteoarthritis Pain Drugs Market: Personal Care (2013-2018) ($ Millions)
Figure Global Personal Care YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Osteoarthritis Pain Drugs Consumption Market Share by Application (2013-2018)
Figure Global Osteoarthritis Pain Drugs Consumption Market Share by Application (2013-2018)
Table Global Osteoarthritis Pain Drugs Value by Application (2013-2018)
Table Global Osteoarthritis Pain Drugs Value Market Share by Application (2013-2018)
Figure Global Osteoarthritis Pain Drugs Value Market Share by Application (2013-2018)
Table Global Osteoarthritis Pain Drugs Sale Price by Application (2013-2018)
Table Global Osteoarthritis Pain Drugs Sales by Players (2016-2018) (M Dose)
Table Global Osteoarthritis Pain Drugs Sales Market Share by Players (2016-2018)
Figure Global Osteoarthritis Pain Drugs Sales Market Share by Players in 2016
Figure Global Osteoarthritis Pain Drugs Sales Market Share by Players in 2017
Table Global Osteoarthritis Pain Drugs Revenue by Players (2016-2018) ($ Millions)
Table Global Osteoarthritis Pain Drugs Revenue Market Share by Players (2016-2018)
Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Players in 2016
Figure Global Osteoarthritis Pain Drugs Revenue Market Share by Players in 2017
Table Global Osteoarthritis Pain Drugs Sale Price by Players (2016-2018)
Figure Global Osteoarthritis Pain Drugs Sale Price by Players in 2017
Table Global Osteoarthritis Pain Drugs Manufacturing Base Distribution and Sales Area by Players
Table Players Osteoarthritis Pain Drugs Products Offered
Table Osteoarthritis Pain Drugs Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Osteoarthritis Pain Drugs Consumption by Regions 2013-2018 (M Dose)
Table Global Osteoarthritis Pain Drugs Consumption Market Share by Regions 2013-2018
Figure Global Osteoarthritis Pain Drugs Consumption Market Share by Regions 2013-2018
Table Global Osteoarthritis Pain Drugs Value by Regions 2013-2018 ($ Millions)
Table Global Osteoarthritis Pain Drugs Value Market Share by Regions 2013-2018
Figure Global Osteoarthritis Pain Drugs Value Market Share by Regions 2013-2018
Figure Americas Osteoarthritis Pain Drugs Consumption 2013-2018 (M Dose)
Figure Americas Osteoarthritis Pain Drugs Value 2013-2018 ($ Millions)
Figure APAC Osteoarthritis Pain Drugs Consumption 2013-2018 (M Dose)
Figure APAC Osteoarthritis Pain Drugs Value 2013-2018 ($ Millions)
Figure Europe Osteoarthritis Pain Drugs Consumption 2013-2018 (M Dose)
Figure Europe Osteoarthritis Pain Drugs Value 2013-2018 ($ Millions)
Figure Middle East & Africa Osteoarthritis Pain Drugs Consumption 2013-2018 (M Dose)
Figure Middle East & Africa Osteoarthritis Pain Drugs Value 2013-2018 ($ Millions)
Table Americas Osteoarthritis Pain Drugs Consumption by Countries (2013-2018) (M Dose)
Table Americas Osteoarthritis Pain Drugs Consumption Market Share by Countries (2013-2018)
Figure Americas Osteoarthritis Pain Drugs Consumption Market Share by Countries in 2017
Table Americas Osteoarthritis Pain Drugs Value by Countries (2013-2018) ($ Millions)
Table Americas Osteoarthritis Pain Drugs Value Market Share by Countries (2013-2018)
Figure Americas Osteoarthritis Pain Drugs Value Market Share by Countries in 2017
Table Americas Osteoarthritis Pain Drugs Consumption by Type (2013-2018) (M Dose)
Table Americas Osteoarthritis Pain Drugs Consumption Market Share by Type (2013-2018)
Figure Americas Osteoarthritis Pain Drugs Consumption Market Share by Type in 2017
Table Americas Osteoarthritis Pain Drugs Consumption by Application (2013-2018) (M Dose)
Table Americas Osteoarthritis Pain Drugs Consumption Market Share by Application (2013-2018)
Figure Americas Osteoarthritis Pain Drugs Consumption Market Share by Application in 2017
Figure United States Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure United States Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Figure Canada Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure Canada Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Figure Mexico Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure Mexico Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Table APAC Osteoarthritis Pain Drugs Consumption by Countries (2013-2018) (M Dose)
Table APAC Osteoarthritis Pain Drugs Consumption Market Share by Countries (2013-2018)
Figure APAC Osteoarthritis Pain Drugs Consumption Market Share by Countries in 2017
Table APAC Osteoarthritis Pain Drugs Value by Countries (2013-2018) ($ Millions)
Table APAC Osteoarthritis Pain Drugs Value Market Share by Countries (2013-2018)
Figure APAC Osteoarthritis Pain Drugs Value Market Share by Countries in 2017
Table APAC Osteoarthritis Pain Drugs Consumption by Type (2013-2018) (M Dose)
Table APAC Osteoarthritis Pain Drugs Consumption Market Share by Type (2013-2018)
Figure APAC Osteoarthritis Pain Drugs Consumption Market Share by Type in 2017
Table APAC Osteoarthritis Pain Drugs Consumption by Application (2013-2018) (M Dose)
Table APAC Osteoarthritis Pain Drugs Consumption Market Share by Application (2013-2018)
Figure APAC Osteoarthritis Pain Drugs Consumption Market Share by Application in 2017
Figure China Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure China Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Figure Japan Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure Japan Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Figure Korea Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure Korea Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure Southeast Asia Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Figure India Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure India Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Figure Australia Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure Australia Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Table Europe Osteoarthritis Pain Drugs Consumption by Countries (2013-2018) (M Dose)
Table Europe Osteoarthritis Pain Drugs Consumption Market Share by Countries (2013-2018)
Figure Europe Osteoarthritis Pain Drugs Consumption Market Share by Countries in 2017
Table Europe Osteoarthritis Pain Drugs Value by Countries (2013-2018) ($ Millions)
Table Europe Osteoarthritis Pain Drugs Value Market Share by Countries (2013-2018)
Figure Europe Osteoarthritis Pain Drugs Value Market Share by Countries in 2017
Table Europe Osteoarthritis Pain Drugs Consumption by Type (2013-2018) (M Dose)
Table Europe Osteoarthritis Pain Drugs Consumption Market Share by Type (2013-2018)
Figure Europe Osteoarthritis Pain Drugs Consumption Market Share by Type in 2017
Table Europe Osteoarthritis Pain Drugs Consumption by Application (2013-2018) (M Dose)
Table Europe Osteoarthritis Pain Drugs Consumption Market Share by Application (2013-2018)
Figure Europe Osteoarthritis Pain Drugs Consumption Market Share by Application in 2017
Figure Germany Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure Germany Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Figure France Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure France Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Figure UK Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure UK Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Figure Italy Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure Italy Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Figure Russia Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure Russia Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Figure Spain Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure Spain Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Osteoarthritis Pain Drugs Consumption by Countries (2013-2018) (M Dose)
Table Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Countries in 2017
Table Middle East & Africa Osteoarthritis Pain Drugs Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Osteoarthritis Pain Drugs Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Osteoarthritis Pain Drugs Value Market Share by Countries in 2017
Table Middle East & Africa Osteoarthritis Pain Drugs Consumption by Type (2013-2018) (M Dose)
Table Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Type in 2017
Table Middle East & Africa Osteoarthritis Pain Drugs Consumption by Application (2013-2018) (M Dose)
Table Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Osteoarthritis Pain Drugs Consumption Market Share by Application in 2017
Figure Egypt Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure Egypt Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Figure South Africa Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure South Africa Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Figure Israel Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure Israel Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Figure Turkey Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure Turkey Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Osteoarthritis Pain Drugs Consumption Growth 2013-2018 (M Dose)
Figure GCC Countries Osteoarthritis Pain Drugs Value Growth 2013-2018 ($ Millions)
Table Osteoarthritis Pain Drugs Distributors List
Table Osteoarthritis Pain Drugs Customer List
Figure Global Osteoarthritis Pain Drugs Consumption Growth Rate Forecast (2018-2023) (M Dose)
Figure Global Osteoarthritis Pain Drugs Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Osteoarthritis Pain Drugs Consumption Forecast by Countries (2018-2023) (M Dose)
Table Global Osteoarthritis Pain Drugs Consumption Market Forecast by Regions
Table Global Osteoarthritis Pain Drugs Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Osteoarthritis Pain Drugs Value Market Share Forecast by Regions
Figure Americas Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure Americas Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure APAC Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure APAC Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure Europe Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure Europe Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure Middle East & Africa Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure Middle East & Africa Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure United States Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure United States Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure Canada Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure Canada Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure Mexico Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure Mexico Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure Brazil Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure Brazil Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure China Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure China Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure Japan Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure Japan Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure Korea Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure Korea Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure Southeast Asia Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure Southeast Asia Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure India Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure India Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure Australia Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure Australia Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure Germany Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure Germany Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure France Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure France Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure UK Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure UK Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure Italy Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure Italy Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure Russia Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure Russia Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure Spain Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure Spain Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure Egypt Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure Egypt Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure South Africa Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure South Africa Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure Israel Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure Israel Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure Turkey Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure Turkey Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Figure GCC Countries Osteoarthritis Pain Drugs Consumption 2018-2023 (M Dose)
Figure GCC Countries Osteoarthritis Pain Drugs Value 2018-2023 ($ Millions)
Table Global Osteoarthritis Pain Drugs Consumption Forecast by Type (2018-2023) (M Dose)
Table Global Osteoarthritis Pain Drugs Consumption Market Share Forecast by Type (2018-2023)
Table Global Osteoarthritis Pain Drugs Value Forecast by Type (2018-2023) ($ Millions)
Table Global Osteoarthritis Pain Drugs Value Market Share Forecast by Type (2018-2023)
Table Global Osteoarthritis Pain Drugs Consumption Forecast by Application (2018-2023) (M Dose)
Table Global Osteoarthritis Pain Drugs Consumption Market Share Forecast by Application (2018-2023)
Table Global Osteoarthritis Pain Drugs Value Forecast by Application (2018-2023) ($ Millions)
Table Global Osteoarthritis Pain Drugs Value Market Share Forecast by Application (2018-2023)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Osteoarthritis Pain Drugs Market Share (2016-2018)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Osteoarthritis Pain Drugs Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline Osteoarthritis Pain Drugs Market Share (2016-2018)
Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mylan Osteoarthritis Pain Drugs Market Share (2016-2018)
Table Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lilly Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Lilly Osteoarthritis Pain Drugs Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Osteoarthritis Pain Drugs Market Share (2016-2018)
Table Abbott Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Laboratories Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Abbott Laboratories Osteoarthritis Pain Drugs Market Share (2016-2018)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bayer Osteoarthritis Pain Drugs Market Share (2016-2018)
Table Almatica Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Almatica Pharma Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Almatica Pharma Osteoarthritis Pain Drugs Market Share (2016-2018)
Table TEVA Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table TEVA Osteoarthritis Pain Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure TEVA Osteoarthritis Pain Drugs Market Share (2016-2018)
Table Iroko Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
  • Global Rheumatoid Arthritis Drugs Market Professional Survey Report 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 104
    This report studies the global Rheumatoid Arthritis Drugs market status and forecast, categorizes the global Rheumatoid Arthritis Drugs market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Rheumatoid arthritis affects approximately 1% of the global population. The condition has dif......
  • Global Rheumatoid Arthritis Drugs Market Size, Status and Forecast 2025
    Published: 04-Jul-2018        Price: US 3300 Onwards        Pages: 94
    This report studies the global Rheumatoid Arthritis Drugs market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Rheumatoid Arthritis Drugs market by companies, region, type and end-use industry. In 2017, the global Rheumatoid Arthritis Drugs market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025. This report focuses on the g......
  • Global Rheumatoid Arthritis Drugs Sales Market Report 2018
    Published: 18-Jun-2018        Price: US 4000 Onwards        Pages: 100
    This report studies the global Rheumatoid Arthritis Drugs market status and forecast, categorizes the global Rheumatoid Arthritis Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Rheumatoid arthritis affects approximately 1% of the global population. The condition has different sympto......
  • Global Osteoarthritis Pain Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 18-Jun-2018        Price: US 3480 Onwards        Pages: 137
    The main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis, osteoarthritis in the use of two kinds of painkillers: Painkillers only: Only a simple analgesic effect, but no anti-inflammatory function, such as acetaminophen, tramadol. Acetaminophen side effects, but the analgesic effect is relatively weak, mainly for mild to moderate pain; tramadol analgesic effect is strong, but also side effects are larger, mainly gastrointestinal......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Osteoarthritis Pain Drugs Market 2018, Forecast to 2023
    Published: 18-Jun-2018        Price: US 4880 Onwards        Pages: 133
    The main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis, osteoarthritis in the use of two kinds of painkillers: Painkillers only: Only a simple analgesic effect, but no anti-inflammatory function, such as acetaminophen, tramadol. Acetaminophen side effects, but the analgesic effect is relatively weak, mainly for mild to moderate pain; tramadol analgesic effect is strong, but also side effects are larger, mainly gastrointestinal......
  • Global Rheumatoid Arthritis Drugs Market Research Report 2018
    Published: 18-Jun-2018        Price: US 2900 Onwards        Pages: 92
    This report studies the global Rheumatoid Arthritis Drugs market status and forecast, categorizes the global Rheumatoid Arthritis Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. Rheumatoid arthritis affects approximately 1% of the global population. The condition has different symptoms such as joint pain, swelling, and stiffness,......
  • Global Sodium Hyaluronate Market Professional Survey Report 2018
    Published: 15-Jun-2018        Price: US 3500 Onwards        Pages: 104
    This report studies the global Sodium Hyaluronate market status and forecast, categorizes the global Sodium Hyaluronate market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). The global Sodium Hyaluronate market is valued at xx million US$ in 2017 and is expected to reach xx million ......
  • United States Osteoarthritis Pain Drugs Market Report 2018
    Published: 07-Jun-2018        Price: US 3800 Onwards        Pages: 114
    In this report, the United States Osteoarthritis Pain Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growt......
  • Global Osteoarthritis Pain Drugs Sales Market Report 2018
    Published: 06-Jun-2018        Price: US 4000 Onwards        Pages: 119
    This report studies the global Osteoarthritis Pain Drugs market status and forecast, categorizes the global Osteoarthritis Pain Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). The main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthriti......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs